(RHI) Robert Half International - Overview
Stock: Staffing, Consulting, Recruiting, Finance, Technology
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 6.01% |
| Yield on Cost 5y | 3.81% |
| Yield CAGR 5y | 11.63% |
| Payout Consistency | 55.8% |
| Payout Ratio | 1.8% |
| Risk 5d forecast | |
|---|---|
| Volatility | 63.2% |
| Relative Tail Risk | -6.43% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.14 |
| Alpha | -62.48 |
| Character TTM | |
|---|---|
| Beta | 1.051 |
| Beta Downside | 1.117 |
| Drawdowns 3y | |
|---|---|
| Max DD | 69.05% |
| CAGR/Max DD | -0.37 |
Description: RHI Robert Half International January 10, 2026
Robert Half Inc. (formerly Robert Half International) delivers talent-solution and business-consulting services through three operating segments: Contract Talent Solutions, Permanent Placement Talent Solutions, and Protiviti. The contract arm supplies contingent professionals across finance, technology, marketing, legal, and customer-support functions, while the permanent segment focuses on full-time placements in accounting, finance, and tax roles. Protiviti provides advisory services covering compliance, finance, technology, data, digital transformation, risk, and internal audit, operating under brands such as Accountemps, Robert Half Finance & Accounting, OfficeTeam, Robert Half Technology, and The Creative Group.
Key quantitative touchpoints (FY 2023) include total revenue of roughly $6.5 billion, an operating margin near 12 %, and a dividend yield of about 2.5 %-both above the sector median. The staffing industry’s growth is being driven by a tight U.S. labor market (unemployment ≈ 3.6 %) and accelerated demand for tech and data-analytics talent, which has helped Robert Half’s contract-staffing volume rise ~ 8 % YoY. Additionally, the firm’s ongoing share-repurchase program (≈ $1 billion authorized) reflects confidence in cash generation and supports earnings per share momentum.
For a deeper dive into how Robert Half’s valuation metrics compare to peers, you might explore ValueRay’s analyst tools for a data-rich perspective.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 133.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA -2.81 > 1.0 |
| NWC/Revenue: -3.19% < 20% (prev 14.56%; Δ -17.75% < -1%) |
| CFO/TA 0.10 > 3% & CFO 292.3m > Net Income 133.0m |
| Net Debt (-464.4m) to EBITDA (138.8m): -3.35 < 3 |
| Current Ratio: 0.88 > 1.5 & < 3 |
| Outstanding Shares: last quarter (99.7m) vs 12m ago -3.26% < -2% |
| Gross Margin: 36.83% > 18% (prev 0.38%; Δ 3645 % > 0.5%) |
| Asset Turnover: 188.4% > 50% (prev 203.0%; Δ -14.68% > 0%) |
| Interest Coverage Ratio: 0.26 > 6 (EBITDA TTM 138.8m / Interest Expense TTM 146.4m) |
Altman Z'' 0.54
| A: -0.06 (Total Current Assets 1.21b - Total Current Liabilities 1.38b) / Total Assets 2.86b |
| B: 0.0 (Retained Earnings 0.0 / Total Assets 2.86b) |
| C: 0.01 (EBIT TTM 37.4m / Avg Total Assets 2.86b) |
| D: 0.81 (Book Value of Equity 1.28b / Total Liabilities 1.58b) |
| Altman-Z'' Score: 0.54 = B |
What is the price of RHI shares?
Over the past week, the price has changed by -9.27%, over one month by +12.54%, over three months by +23.39% and over the past year by -45.06%.
Is RHI a buy, sell or hold?
- StrongBuy: 2
- Buy: 0
- Hold: 6
- Sell: 1
- StrongSell: 2
What are the forecasts/targets for the RHI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 32 | 1.9% |
| Analysts Target Price | 32 | 1.9% |
| ValueRay Target Price | 29.2 | -7.1% |
RHI Fundamental Data Overview February 01, 2026
P/E Forward = 19.802
P/S = 0.6451
P/B = 2.7442
P/EG = 1.3729
Revenue TTM = 5.38b USD
EBIT TTM = 37.4m USD
EBITDA TTM = 138.8m USD
Long Term Debt = unknown (none)
Short Term Debt = 69.7m USD (from shortTermDebt, two quarters ago)
Debt = 240.8m USD (from shortLongTermDebtTotal, two quarters ago)
Net Debt = -464.4m USD (from netDebt column, last quarter)
Enterprise Value = 3.30b USD (3.52b + Debt 240.8m - CCE 464.4m)
Interest Coverage Ratio = 0.26 (Ebit TTM 37.4m / Interest Expense TTM 146.4m)
EV/FCF = 13.94x (Enterprise Value 3.30b / FCF TTM 236.6m)
FCF Yield = 7.17% (FCF TTM 236.6m / Enterprise Value 3.30b)
FCF Margin = 4.40% (FCF TTM 236.6m / Revenue TTM 5.38b)
Net Margin = 2.47% (Net Income TTM 133.0m / Revenue TTM 5.38b)
Gross Margin = 36.83% ((Revenue TTM 5.38b - Cost of Revenue TTM 3.40b) / Revenue TTM)
Gross Margin QoQ = 37.59% (prev 37.23%)
Tobins Q-Ratio = 1.15 (Enterprise Value 3.30b / Total Assets 2.86b)
Interest Expense / Debt = 8.72% (Interest Expense 21.0m / Debt 240.8m)
Taxrate = 32.31% (15.2m / 46.9m)
NOPAT = 25.3m (EBIT 37.4m * (1 - 32.31%))
Current Ratio = 0.88 (Total Current Assets 1.21b / Total Current Liabilities 1.38b)
Debt / Equity = 0.19 (Debt 240.8m / totalStockholderEquity, last quarter 1.28b)
Debt / EBITDA = -3.35 (Net Debt -464.4m / EBITDA 138.8m)
Debt / FCF = -1.96 (Net Debt -464.4m / FCF TTM 236.6m)
Total Stockholder Equity = 1.30b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.66% (Net Income 133.0m / Total Assets 2.86b)
RoE = 10.26% (Net Income TTM 133.0m / Total Stockholder Equity 1.30b)
RoCE = 2.54% (EBIT 37.4m / Capital Employed (Total Assets 2.86b - Current Liab 1.38b))
RoIC = 1.94% (NOPAT 25.3m / Invested Capital 1.30b)
WACC = 9.54% (E(3.52b)/V(3.76b) * Re(9.79%) + D(240.8m)/V(3.76b) * Rd(8.72%) * (1-Tc(0.32)))
Discount Rate = 9.79% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.79%
[DCF Debug] Terminal Value 69.09% ; FCFF base≈268.5m ; Y1≈223.0m ; Y5≈162.9m
Fair Price DCF = 27.49 (EV 2.32b - Net Debt -464.4m = Equity 2.78b / Shares 101.2m; r=9.54% [WACC]; 5y FCF grow -20.43% → 2.90% )
EPS Correlation: -91.13 | EPS CAGR: -34.00% | SUE: 0.29 | # QB: 0
Revenue Correlation: -97.59 | Revenue CAGR: -8.47% | SUE: 0.47 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.13 | Chg30d=+0.019 | Revisions Net=-3 | Analysts=5
EPS current Year (2026-12-31): EPS=1.60 | Chg30d=-0.041 | Revisions Net=-4 | Growth EPS=+20.1% | Growth Revenue=+0.0%
EPS next Year (2027-12-31): EPS=2.32 | Chg30d=-0.077 | Revisions Net=-2 | Growth EPS=+45.6% | Growth Revenue=+5.6%